Bruce Quinn, M.D., Ph.D.

  • Senior Health Policy Specialist
  • Boston
  • 617 832 1291 direct
  • 617 832 7000 fax

Bruce Quinn, MD Ph.D., is a national expert on Medicare policy, the impact of health reform on innovation and the crafting of successful business strategies within the U.S. healthcare reimbursement system. Dr. Quinn has worked successfully with both large and small companies in overcoming hurdles to commercialization through negotiation, understanding insightful ways to use the existing system to advantage and the mechanisms of policy change. Since 2008, he has been a full time business strategist working with attorney and policy teams for healthcare and life sciences clients in the firm’s Government Strategies practice.

Dr. Quinn travels nationwide to speak on health reform issues and publishes actively, recently writing two peer reviewed policy articles on advanced diagnostics. Before joining Foley Hoag LLP, he was the regional Medicare medical director for the California Part B program, with authority for final coverage decisions for approximately 15% of the U.S. Medicare program. Earlier in his career, Dr. Quinn was a physician executive in the Health & Life Sciences division of Accenture, working with the pharma, biotech and genomics industries. He is a board-certified pathologist. As a physician-scientist on the faculty of Northwestern University School of Medicine, Dr. Quinn led pathology research for Northwestern’s NIH-funded Alzheimer Research Center. Earlier, he also held academic positions at New York University School of Medicine and the UCLA Center for Health Sciences and is the author or co-author on 30 scientific publications.

SPEECHES AND CONFERENCES

  • Speaker, Payers and Assessment of Clinical Utility for Companion Diagnostics, This Week in Money and Personalized Medicine, Podcast, November 2011
  • Speaker, Personalized diagnostics in a time of rapid change, Institute of Medicine, Workshop on Personalized Medicine, Washington DC, November 2011
  • Speaker, Molecular Diagnostics Makers Face Tougher Standards for Payment, The Burrill Report, Podcast, October 2011 
  • Speaker, Navigating through Emerging CMS Policies, 5th Annual Device Reimbursement Conference, Chicago, IL, July 2011
  • Speaker, Weathering the Perfect Storm: What you need to know about impending reimbursement, regulation and coding reforms, national webinar sponsored by Xifin, Inc., San Diego, CA, July 2011
  • Speaker, The Seven Sins of Evidence Based Medicine, Scientia Advisors Luminary Series, Boston, MA, June 2011
  • Speaker, From Translational Science to Commercialization.  NMI Workshop: Tubingen, Germany, May 2011
  • Speaker, Medicare Coverage and Reimbursement 2011, UCSF Course, From Idea to IPO (Steve Burrill, Course Director), February, 2011
  • Speaker, The Future of Drug Development in an Increasingly Evidence-based Environment; and How are Drugs and Biologics Paid for by Public and Private Payers?, UCSF/American Course on Drug and Regulatory Sciences, San Francisco, CA, October 2010
  • Panelist, Diagnostic Testing, Imaging and Personalized Medicine Panel: The View from Medicare and Industry on Coverage & Payment, JP Morgan 28th Annual Life Sciences Conference, San Francisco, CA, January 2010
  • Speaker, The (Giant) Missing Link: Payors Present Hurdles and Opportunities for Personalized Medicine, Personalized Medicine World Conference 2010, Silicon Valley, CA, January 2010
  • Speaker, Emerging Importance of Companion Diagnostics in Drug Development, New York Academy of Sciences, September 2009
  • Panelist, Reimbursement Hurdles, National Cancer Policy Forum (NCPF) Workshop: Policy Issues in the Development of Personalized Medicine in Oncology, Institute of Medicine of the National Academies, Washington, DC, June 2009
  • Speaker, U.S. Payment Systems, European In Vitro Diagnostic Regulatory & Reimbursement Conference, Frankfurt, Germany, February 2009
  • Panelist, National Summit on Personalized Health Care: Innovation in Health Care Delivery, Deer Valley, Utah, November 2008
  • Payor Perspective, Analytical and Clinical Metrics used in the Health Technology Assessment Process, Discovery2Diagnostics Conference & Exhibition, San Diego, California, October 2008
  • Panelist, Challenges of Moving Personalized Health Care Forward: Public Policy, Regulatory, Consumers, and Payer, Personalized Health Care National Conference, Ohio State University, October 2008
  • Speaker, Preparing for the Next Frontier: Tailored Therapies and Smaller Faster Studies, American Conference 10 National Conference on Managing Legal Risks in Structuring & Conduction Clinical Trials, September 2008
  • Speaker, Implementing Personalized Medicine: American Association for the Advancement of Science (AAAS) and the Food and Drug Law Institute (FDLI) Legal, Regulatory and Policy Seminar, Washington, DC, June 2008
  • Panelist, If You Build It, Will They Pay? The Coming Challenges Of Coverage And Reimbursement In The Innovative Age, Mass Biotech Annual Meeting, Boston, Massachusetts, May 2008

publications